Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 6,762,000 | 6,460,000 | 6,939,000 | 6,250,000 | 6,232,000 |
| Cost of Goods | 1,307,000 | 1,453,000 | 1,440,000 | 1,238,000 | 1,317,000 |
| Gross Profit | 5,455,000 | 5,007,000 | 5,499,000 | 5,012,000 | 4,915,000 |
| Operating Expenses | 4,346,000 | 4,171,000 | 6,090,000 | 3,306,000 | 3,715,000 |
| Operating Income | 1,109,000 | 836,000 | -591,000 | 1,706,000 | 1,200,000 |
| Interest Expense | 253,000 | 213,000 | 131,000 | 128,000 | 121,000 |
| Other Income | 10,000 | 15,000 | 7,000 | 14,000 | 7,000 |
| Pre-tax Income | 866,000 | 638,000 | -715,000 | 1,592,000 | 1,086,000 |
| Income Tax | 69,000 | 132,000 | -195,000 | 344,000 | 255,000 |
| Net Income Continuous | 797,000 | 506,000 | -520,000 | 1,248,000 | 831,000 |
| Minority Interests | 1,000 | 2,000 | 4,000 | 2,000 | 8,000 |
| Net Income | $796,000 | $504,000 | $-524,000 | $1,246,000 | $823,000 |
| EPS Basic Total Ops | 0.32 | 0.20 | -0.21 | 0.50 | 0.33 |
| EPS Basic Continuous Ops | 0.32 | 0.20 | -0.21 | 0.50 | 0.33 |
| EPS Diluted Total Ops | 0.32 | 0.20 | -0.21 | 0.50 | 0.33 |
| EPS Diluted Continuous Ops | 0.32 | 0.20 | -0.21 | 0.50 | 0.33 |
| EBITDA(a) | $1,807,000 | $1,548,000 | $2,014,000 | $2,094,000 | $2,139,000 |